Skip to content

French Language Validation of the 5-minutes Montreal Cognitive Assessment (MoCA)

French Language Validation of the Phone Version of the Montreal Cognitive Assessment (MoCA)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03232697
Acronym
MoCATEL
Enrollment
236
Registered
2017-07-28
Start date
2017-07-12
Completion date
2019-08-08
Last updated
2020-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Symptom, Evaluations, Diagnostic Self

Brief summary

The aim of the study is to validate a french version of the 5 minutes version of the Montreal Cognitive Assessment as compared to the french full version of this test.

Detailed description

The Montreal Cognitive Assessment (MOCA) is a test used to detect cognitive impairments. This test is available in different languages including french. A short version (the 5 minutes MOCA) has also been validated through a phone call use that allows to develop some epidemiological approaches. Nevertheless, this short version has not been validated in french. The main aim of the study is to validate the french translation of the short version of the MOCA as compared the the full french version of the test. To validate the short version, several groups of subjects will be included : healthy subjects, Alzheimer disease patients, Parkinson or Huntington diseases patients as well as diabetic patients. The inclusion of both healthy subjects and patients with different types of cognitive impairments will allow to validate the short version of the test. All subjects and patients will first be submitted to the full version of the MOCA during a face to face procedure. Thirty to forty days later, they will be submitted to the short version of the test through a phone call performed by an independent rater. Subgroups of healthy subjects and patients will also be used to determine the test-retest and inter-rater reliability of the short version of the MOCA.

Interventions

DIAGNOSTIC_TESTFull version of the Montreal Cognitive Assessment

Patients or subjects will be submitted to the full version of the MOCA

DIAGNOSTIC_TEST5 minutes version of the Montreal Cognitive Assessment

The same patients and subjects will be submitted to the 5 minutes version of the MOCA through a phone call

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Different populations including subjects with or without cognitive impairment will be used to determine the accuracy of a short version of the MOCA as compared to the full version of this scale.

Eligibility

Sex/Gender
ALL
Age
40 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy Volunteers * Volunteers, BMI \<26 * free from neurological, psychiatric, metabolic or cardiac pathologies; * Absence of active metabolic or cardiac diseases, unstabilized under treatment * Pregnant test negative Patients * Patients suffering from pathologies that may be accompanied by cognitive decline or dementia (Alzheimer's disease, Parkinson's and Huntington's disease, diabetes) that meet the usual diagnostic criteria for these diseases; * Patients should not start treatment of a new therapeutic class under test

Exclusion criteria

* Pregnant or nursing women. * Illiterate subjects * Presence of uncorrected visual or auditory disturbances * Alcohol use disorder observed at the Mini International Neuropsychiatric Inventory (MINI); * Substance use disorder observed at the MINI; * Participation in a therapeutic trial or in an exclusion period from a previous clinical trial; * Patient whose physical or mental condition does not allow them to pass the study tests; * Persons under guardianship or under trusteeship; * Recent cognitive assessment (less than 6 months) by the classic MoCA

Design outcomes

Primary

MeasureTime frameDescription
Correlation between scores obtained with the different versions of the MOCA30 to 40 daysTo measure the correlation between the results obtained at the short and full versions of the MOCA

Secondary

MeasureTime frameDescription
Performance of the short version of the MOCA30 to 40 daysReceiver operator characteristic (ROC) analyses of the short version of MOCA to determine cognitive impairment as compared to full version as a gold-standard
Test-retest reliability30 to 40 daysTo determine the test-retest reliability of the short version of the MOCA
Inter-rater reliability30 to 40 daysTo determine the inter-rater reliability of the short version of the MOCA

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026